Genopathy
Gene-Disorder Association · Article
Gene
CHEK2
Checkpoint Kinase 2
Disorder
Neuroblastoma 3
First reported 1976
Key publication · disorder Combination chemotherapy with adramycin (NSC-123127) and dimethyl triazeno imidazole carboxamide (DTIC) (NSC-45388) in children with metastatic solid tumors.Medical and pediatric oncology · 1976
Manually curated
Association Review

In brief

The association between CHEK2 (Checkpoint Kinase 2) and Neuroblastoma 3 is reported, with clinical genetic testing available.

Sources 1
Clinical variants 0
Symptoms 0
Compounds 0
Trials 0
Publications 0
01
At a glance

Association overview

A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.

Request access
02
Provenance

Evidence and sources

1 source

Every contributing database and publication behind this association, with evidence type, strength, accessions and deep links.

Request access
03
CHEK2

The gene

2 source summaries

A gene summary alongside the source descriptions it was distilled from.

Request access
04
Neuroblastoma 3

The disorder

4 database identifiers

The disorder’s summary, prevalence, aliases and cross-reference identifiers (OMIM, Orphanet, MONDO, ICD-10, MedGen).

Request access
05
Provenance

References & sources

3 references

Every source and publication cited across this dossier, as one numbered reference list.

Request access